Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -763.90% is 24% above its 5-year average of -1002.32%, near the high end of its 5-year range (-2087.89%–-500.93%).
15.70% above its 12-month average of -906.21%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1526.66%.
OPERATING MARGIN
-763.90%
OPERATING MARGIN AVG TTM
-906.21%
OPERATING MARGIN AVG 3Y
-1218.49%
OPERATING MARGIN AVG 5Y
-1002.32%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+15.70%
CURRENT VS 3Y AVG
+37.31%
CURRENT VS 5Y AVG
+23.79%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Femasys Inc.
Market Cap
$6.10M
Operating Margin
-763.90%
TTM Avg
-906.21%
3Y Avg
-1218.49%
5Y Avg
-1002.32%
Market Cap
$6.10M
Operating Margin
-43737.46%
TTM Avg
-33857.66%
3Y Avg
-147235.02%
5Y Avg
-109633.70%
Market Cap
$6.09M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-71.62%
Market Cap
$6.03M
Operating Margin
-9154.62%
TTM Avg
-6279.74%
3Y Avg
-3924.25%
5Y Avg
-3328.36%
Market Cap
$6.34M
Operating Margin
-119.54%
TTM Avg
-108.09%
3Y Avg
-117.27%
5Y Avg
-99.55%
Market Cap
$6.44M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.63M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.54M
Operating Margin
-305.03%
TTM Avg
-323.91%
3Y Avg
-495.10%
5Y Avg
-376.97%
Market Cap
$6.72M
Operating Margin
-450.07%
TTM Avg
-699.99%
3Y Avg
-986.00%
5Y Avg
-5433.17%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Femasys Inc. (FEMY) | $6.10M | -763.90% | -906.21% | -1218.49% | -1002.32% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | -43737.46% | -33857.66% | -147235.02% | -109633.70% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | 0.00% | 0.00% | 0.00% | -71.62% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.03M | -9154.62% | -6279.74% | -3924.25% | -3328.36% |
| Biomerica, Inc. (BMRA)vs › | $6.34M | -119.54% | -108.09% | -117.27% | -99.55% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | 0.00% | 0.00% | 0.00% | 0.00% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.54M | -305.03% | -323.91% | -495.10% | -376.97% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | -450.07% | -699.99% | -986.00% | -5433.17% |
| Aclarion, Inc. (ACON)vs › | $6.74M | -9312.55% | -10684.89% | -9259.36% | -8523.06% |
Gross Margin
62.0%
Operating Margin
-763.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -1526.66% |
| 2026-03-31 | -994.03% |
| 2025-12-31 | -568.33% |
| 2025-09-30 | -500.93% |
| 2025-06-30 | -941.09% |
| 2025-03-31 | -1600.11% |
| 2024-12-31 | -812.03% |
| 2024-09-30 | -922.39% |
| 2024-06-30 | -2023.69% |
| 2024-03-31 | -1277.07% |
| 2023-12-31 | -2087.89% |
| 2023-09-30 | -1670.18% |
| 2023-06-30 | -916.02% |
| 2023-03-31 | -1034.64% |
| 2022-12-31 | -1280.87% |
| 2022-09-30 | -879.88% |
| 2022-06-30 | -877.55% |
| 2022-03-31 | -896.92% |
| 2021-12-31 | -927.05% |
| 2021-09-30 | -835.16% |
| 2021-06-30 | -583.14% |
| 2021-03-31 | -553.88% |
| 2020-12-31 | -592.41% |
| 2020-09-30 | -499.63% |
| 2020-06-30 | -809.69% |
| 2020-03-31 | -852.23% |
